ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GC36704-50mg |
|
855527-92-3 |
NBI-74330
|
0 | C32H27F4N5O3 | |
GC36704-10mg |
|
855527-92-3 |
NBI-74330
|
0 | C32H27F4N5O3 | |
GC36704-5mg |
|
855527-92-3 |
NBI-74330
|
0 | C32H27F4N5O3 | |
GC36704-10mM (in 1mL DMSO) |
|
855527-92-3 |
NBI-74330
|
0 | C32H27F4N5O3 | |
GC36703-5mg |
|
883715-21-7 |
N-Benzyloleamide
|
0 | C26H43NO2 | |
GC36702-25mg |
|
333352-59-3 |
NBD-557
|
0 | C17H24BrN3O2 | |
GC36702-10mg |
|
333352-59-3 |
NBD-557
|
0 | C17H24BrN3O2 | |
GC36702-5mg |
|
333352-59-3 |
NBD-557
|
0 | C17H24BrN3O2 | |
GC36702-10mM (in 1mL DMSO) |
|
333352-59-3 |
NBD-557
|
0 | C17H24BrN3O2 | |
GC36701-5mg |
|
686301-48-4 |
NB001
|
0 | C12H20N6O | |
GC36701-1mg |
|
686301-48-4 |
NB001
|
0 | C12H20N6O | |
GC36700-5mg |
|
1508256-20-9 |
Nazartinib S-enantiomer
|
0 | C26H31ClN6O2 | |
GC36700-2mg |
|
1508256-20-9 |
Nazartinib S-enantiomer
|
0 | C26H31ClN6O2 | |
GC36700-10mM (in 1mL DMSO) |
|
1508256-20-9 |
Nazartinib S-enantiomer
|
0 | C26H31ClN6O2 | |
GC36699-100mg |
|
1508250-72-3 |
Nazartinib mesylate
|
0 | C27H35ClN6O5S | |
GC36699-50mg |
|
1508250-72-3 |
Nazartinib mesylate
|
0 | C27H35ClN6O5S | |
GC36699-10mg |
|
1508250-72-3 |
Nazartinib mesylate
|
0 | C27H35ClN6O5S | |
GC36699-5mg |
|
1508250-72-3 |
Nazartinib mesylate
|
0 | C27H35ClN6O5S | |
GC36697-100mg |
|
1355631-24-1 |
Nav1.7 inhibitor
|
0 | C15H11Cl3FNO4S | |
GC36697-50mg |
|
1355631-24-1 |
Nav1.7 inhibitor
|
0 | C15H11Cl3FNO4S | |